PB2452 in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Conditions:   Hemorrhage;   Urgent Surgery;   Invasive Procedure Intervention:   Drug: PB2452 Infusion Sponsor:   PhaseBio Pharmaceuticals Inc. Not yet recruiting

Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials